日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Biological activity of a stable 6-aryl-2-benzoyl-pyridine colchicine-binding site inhibitor, 60c, in metastatic, triple-negative breast cancer.

稳定的 6-芳基-2-苯甲酰基-吡啶秋水仙碱结合位点抑制剂 60c 在转移性三阴性乳腺癌中的生物活性

Oluwalana Damilola, Adeleye Kelli L, Krutilina Raisa I, Chen Hao, Playa Hilaire, Deng Shanshan, Parke Deanna N, Abernathy John, Middleton Leona, Cullom Alexandra, Thalluri Bhargavi, Ma Dejian, Meibohm Bernd, Miller Duane D, Seagroves Tiffany N, Li Wei

Stevens-Johnson Syndrome in a Patient on Concomitant Treatment with Levetiracetam and Trimethoprim/Sulfamethoxazole

同时服用左乙拉西坦和甲氧苄啶/磺胺甲噁唑的患者出现史蒂文斯-约翰逊综合征

Tabet Aoul, Amel; Al-Nasseri, Abraheim; Hall, Chase; He, Chun; Abernathy, John

CAR T cell therapy in solid tumors: A review of current clinical trials

CAR-T细胞疗法在实体瘤中的应用:当前临床试验综述

Patel, Urvi; Abernathy, John; Savani, Bipin N; Oluwole, Olalekan; Sengsayadeth, Salyka; Dholaria, Bhagirathbhai